Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2025
Tumor-Derived Interleukin 35 Promotes Fibrosis in the Tumor Microenvironment of Pancreatic Cancer by Activating Pancreatic Stellate CellsHui Li, Huizhi Sun, Jing Liu, et al.
Cancer Letters|February 4, 2017
HIF-2-dependent expression of stem cell factor promotes metastasis in hepatocellular carcinomaXiuchao Wang, Jie Dong, Li Jia, et al.
Cancer Research|November 12, 2014
LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancerTiansuo Zhao, He Ren, Jing Li, et al.
Cancer Letters|May 30, 2021
PERK-eIF2α-ERK1/2 axis drives mesenchymal-endothelial transition of cancer-associated fibroblasts in pancreatic cancerWenrun Cai, Xugang Sun, Fanjie Jin, et al.
Gut|January 9, 2026
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapyJing Liu, Xupeng Hou, Lin Li, et al.
Gut|March 6, 2021
ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4Tianxing Zhou, Jing Liu, Yongjie Xie, et al.
Oncogene|January 19, 2024
Tumor-derived interleukin 35 mediates the dissemination of gemcitabine resistance in pancreatic adenocarcinomaHuizhi Sun, Yi Ge, Jing Liu, et al.
Cancer Research|April 12, 2022
Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic CancerXiuchao Wang, Yunzhan Li, Zekun Li, et al.
Signal Transduction and Targeted Therapy|July 13, 2023
BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesisChongbiao Huang, Hui Li, Yang Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 23, 2022
CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent MechanismWeishuai Liu, Xiaozhou Yu, Yudong Yuan, et al.
Pageof 7